Download Pharmacology - Shelbye's CSON Notes Blog

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of antiandrogens wikipedia , lookup

Environmental persistent pharmaceutical pollutant wikipedia , lookup

Discovery and development of angiotensin receptor blockers wikipedia , lookup

5-HT3 antagonist wikipedia , lookup

Pharmacokinetics wikipedia , lookup

5-HT2C receptor agonist wikipedia , lookup

Environmental impact of pharmaceuticals and personal care products wikipedia , lookup

Toxicodynamics wikipedia , lookup

Stimulant wikipedia , lookup

Drug interaction wikipedia , lookup

Theralizumab wikipedia , lookup

Methadone wikipedia , lookup

Bilastine wikipedia , lookup

Cannabinoid receptor antagonist wikipedia , lookup

NK1 receptor antagonist wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Dextropropoxyphene wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
Pharmacology
Spring 09 – Unit 2
Carla Hilton, MSN, RN, CNE
Lecture 3
Chapters 28, 77
Learning Outcomes
• Compare and contrast fundamental
concepts related to the use of specific
central nervous system drugs, including
those used for management of pain, drugs
related to the maintenance of bowel
function and the management of
constipation.
• Acquire a working framework for studying
drug classifications and nursing
implications.
Classifications:
Opioid (Narcotic) Analgesics,
Opioid Antagonists, and Non-opioid
Centrally Acting Analgesics
Chapter 28
Intro to Opioids
• Chemical class: Opioid vs opiate
– Opiod means they act like an opiate
– Opiates are from poppy seeds
• Functional class: Narcotic Analagesic
• MOA – body peptides (3) enkephalins, endorphins,
dynorphins (they produce their effects at these receptor sites)
• Opioid receptors -
mu, kappa, and delta
– Agonist, partial agonist, antagonist
• Partial agonists produces low to moderate activation alone,
but will block actions of full agonists if given simultaneously
– Strong and moderate to strong
Table 28-1
Opioid Agonists
• Prototypes
– Strong: morphine [Duramorph] CII
– Moderate to strong: codeine [Paveral] CIII
• MOA / TE
– Mimics action of endogenous opioid receptors
(mu) to produce analgesia and thereby relieve
pain
– Other effects include drowsiness, mental
clouding, anxiety reduction, sense of wellbeing. CNS Depressant
– Oral dose is a lot higher than IV in this case
• Adverse Effects
– Resp. depression
• Diminished by “tolerance”
• Most common cause of OD death
– Others
• Constipation, orthostatic hypotension, urinary retention /
urgency, cough suppression, biliary colic, emesis, elevated
ICP (intracranial pressure), dysphoria, sedation, miosis
(small pupils), neurotixicity, immune and hormone
suppression with prolonged use
– Toxicity
• Classic triad (coma, resp. depression, pinpoint pupils)
Miosis- tiny little pin point pupils
Mydriasis- with the d in the word, think dilated pupils
•
ADME (Pharmacokinetics) Nursing implications?
– Given by several routes
– Slowest to fastest
– Time-frame for TE varies by mode of administration
• If you want the drug now, do IV. We need to know how long it takes these to
work
– Denatured in liver
– Hard to cross blood-brain barrier
• Precautions / Contraindications
– Decreased resp reserve, pregnancy, head injury, infants
(crosses placenta) / elderly, hypotension, liver disease
• Interactions
– CNS depressants, antihistamines, antihypertensives, MOAIs*,
antiemetics, amphetamines, agonist-antagonist, antagonists
• Dosage – Highly individualized
– Table 28-6
• Administration
– po, IM, IV, SQ, topical, PCA
– Oral associated with chronic
– Preferably fixed schedule
– Site specific – hazards (epidural, effects
delayed…)
Other Strong Opioids
• Fentanyl (Sublimaze)
– Anesthesia primary use (injectable)
– 100 X mg potency of morphine
– Commonly seen as transdermal
• No children under 2 / none for under 18 less than
100 lbs.
– Transmucosal (popsicle)
• Breakthrough cancer pain
• Store carefully
• very large amts of drug (can kill!)
• Meperidine [Demerol]
– Interacts with several drugs – esp MAOI’s
– Toxic metabolite (had problems in the elderly)
• Avoid use past 48 hrs and not to exceed
600mg/24hr.
• Hydromorphone [Dilaudid]
• Methadone
• Help people addicted to heroin
• Heroin – crosses blood-brain easier
Table 28-6 – Dosing for Opioids
Moderate to Strong Opioid
Agonists
• Codeine
– Usual dose of 30 mg = about same relief as 325
mg of ASA or Tylenol
– Combo meds more effective
– Extremely effective cough suppressant at 10 mg
dose range
• Oxycodone [OxyContin, Percodan] & CR
forms
• Hydrocodone [Lortab, Norco, Vicodin] CIII
• Proproxyphene [Darvon, Darvocet] CIV
Special Clinical Concepts r/t Use of
Opioids
•
•
•
•
Pain assessment – including evaluation!
Dosing amt and schedule
Fear of addiction in clinical setting
Avoiding withdrawal – 20 days or more
– They can have withdrawal symptoms
• Patient controlled anesthesia (PCA)
• Morphine: DOC - heart attack (MI)
• Meperidine [Demerol]: DOC OB
– Doesn’t cross placenta
• Avoid opioids in Head Injury…
Nursing Implications
• Link to ATI pp. 133 (150)
Class: Opioid AgonistAntagonists
• Prototype: pentazocine [Talwin]
– Others: nalbuphine [Nubain], butorphanol
[Stadol]
• MOA - act mostly at mu kappa receptor to
produce analgesia and relieve pain.
– Alone = agonist action
– With agonist = can antagonize (blocks mu receptor)
• Adverse effects – similar to opioids
• ADME (Pharmacokinetics)
– Less respiratory depression, low abuse potential
– Less effective pain relief
– *Can start withdrawal sxms in opioid addiction
Class: Opioid Antagonists
• Prototype: naloxone [Narcan]
• MOA – TE / Use
– competes for opiate site and blocks effects of opioid
agonists / agonist-antagonists – no significant effect
given alone – resulting in REVERSAL of narcotic
• ADME
– Rebound effect (narcan wears off and they are back
under the morphine…)
• Adverse effects: acute withdrawal
• Dosage/Admin: 04. mg IM, IV, SubQ
• Others: naltrexone [ReVia] ETOH/Opioid abuse
Non-opioid
Centrally Acting Analgesics
• Prototype: Tramadol [Ultram]
– Others: clonidine [Duraclon] is another centrally acting analgesic
– pain / HTN
• MOA / TE / Use
– Analog of codeine – binds w mu receptor producing analgesia to
relieve pain. Also blocks re-uptake of norepinephrine (lots of this
in your system)
• ADME (Pharmacokinetics)
– Minimal potential for dependence or resp depression
• Adverse effects
– Rare – most common: sedation, dizziness, HA, dry mouth, and
constipation
• Precautions
– Can intensify other CNS dep. – ABSOLUTELY avoid MAOIs
Laxatives
Chapter 77
Bulk-forming
• Prototype(s): methylcellulose, psyllium
(Metamucil)
• Action / Use
– Behave like dietary fiber – nonabsorbable – swell to
form viscous solution / gel and softening fecal mass
and increasing transit.
– Temp relief of constipation, diarrhea, irritable bowel,
ostomies
• Adverse effects
– Esophageal & intestinal obstruction if not enough fluid  ? If you don’t
take with enough fluid you can obstruct stuff. Builds a brick in the gut
that doesn’t move
(If this, then?)
Surfactants
• Prototype: docusate sodium (Colace)
• Action / Uses
– Lower surface tension of stool and softens by facilitating
penetration of water into the feces
– Act on intestinal wall to inhibit fluid absorption and stimulate
secretion of water and electrolytes into the intestinal lumen.
– Brings water into the stool and makes it softer
• ADME
– Full glass of water
– Sit upright for 30 min (kind of oil based and you can aspirate the
stuff and get pneumonia)
– Effectiveness dose related (min 200 mg/day)
• Adverse reactions – rare
• Dosage: 50 to 500 mg daily ( but usually at least
200 mg a day)
Stimulants
Typically abused the most
• Prototype(s): bisacodyl (Dulcolax), senna
(Senekot)
• Action / Legitimate Uses
– Directly stimulate gut motility, increase secretion of water and
ions into intestine, and reduce water and electrolyte absorption.
– Uses: Treatment of (1) opioid-induced constipation and (2) slow
transit constipation
• Dosage: related to formulation administered
– Take bisacodyl no sooner than 1 hour after ingesting milk or
antacids – do not crush
• Adverse reactions
– Bowel rupture can occur
– If you have gut surgery and your sutures are healing, if you give
them this is makes their gut move and can tear open the incision
Osmotics
• Salts Prototype: sodium phosphate (Fleet) and
magnesium salts
• Action /Uses
– Non-absorbable and retains water in the colon
• Adverse reaction
– Dehydration, diarrhea and loss of water (more with salts than
with glycol)
– Magnesium can accumulate to toxic levels in renal failure
– Sodium can retain fluid – so…. Contraindicated in patients with
heart failure HTN and edema
• Other: glycol (MiraLax) – fewer side effects / safer
Miscellaneous
• Lactulose (sugar base)
– Action / Uses
• Poorly absorbed and cannot be digested – by
product of breakdown results in osmotic diuresis
• Enhances excretion of ammonia in liver failure
– SEs – flatulence, cramping
• Glycerin Suppository
• Polyethylene Glycol-Electrolyte (GoLytely)
– Safe in dehydrated or electrolyte sensitive
Additional Nursing Implications
• High risk patients
– Contraindicated in abdominal pain, nausea,
cramps, regional enteritis, diverticulitis,
ulcerative colitis, acute surgical abdomen,
fecal impaction, bowel obstruction.
• Abuse
• Castor oil (powerful stimulant – avoid at
night – not to children)